Cargando…
A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia
Introduction Pneumomediastinum and pneumothorax are uncommon complications in COVID-19 patients. The exact prevalence, etiology, and outcomes are not well known. We report a case series of patients in our institution with COVID-19 related pneumomediastinum and pneumothorax and address these question...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930020/ https://www.ncbi.nlm.nih.gov/pubmed/35340519 http://dx.doi.org/10.7759/cureus.22247 |
_version_ | 1784670971070775296 |
---|---|
author | Staiano, Peter P Patel, Shaorinkumar Green, Kevin R Louis, Mariam Hatoum, Hadi |
author_facet | Staiano, Peter P Patel, Shaorinkumar Green, Kevin R Louis, Mariam Hatoum, Hadi |
author_sort | Staiano, Peter P |
collection | PubMed |
description | Introduction Pneumomediastinum and pneumothorax are uncommon complications in COVID-19 patients. The exact prevalence, etiology, and outcomes are not well known. We report a case series of patients in our institution with COVID-19 related pneumomediastinum and pneumothorax and address these questions. Methods We conducted a single-center retrospective chart review of patients admitted at our institution with a positive polymerase chain reaction (PCR) confirming the diagnosis of COVID-19. A cohort of 500 potential study candidates was identified, of whom eight were investigated. Demographic data, hospital course, patient co-morbidities, and outcome data were collected. Results Eight patients were included in our study who were identified as having an event (i.e., pneumomediastinum and/or pneumothorax) during the specified timeframe. Overall, 62% of patients were on high-flow nasal cannula with an average FiO(2) of >70%. The average oxygen saturation//fraction of inspired oxygen (SpO(2)/FiO(2)) ratio leading up to an event was 113.7286 (range: 101.11-130.66), and all of the patients not on mechanical ventilation met the criteria for acute respiratory distress syndrome (ARDS) based on the Kigali definition with SpO(2)/FiO(2) < 315. The three patients who developed an event while requiring mechanical ventilation both had PaO(2)/FiO(2) < 100, consistent with severe ARDS at the time of an event. The mean time in days, counted from the day of hospital admission until an event, was 10 days (range: 3-23 days). None of the cases had documented pulmonary parenchymal disease prior to developing COVID-19. To the best of our knowledge, these events were not iatrogenic in nature. Conclusion Secondary spontaneous pneumomediastinum and pneumothorax are rare albeit well-documented phenomena in hospitalized patients with COVID-19 infection. Interestingly, the majority of patients in our study were on high-flow nasal cannula at the time of an event. The majority of previously published data on this topic are on those who required positive pressure ventilation; however, there have been more recent papers that also describe these events in non-mechanically ventilated patients. The exact pathophysiology remains unknown, but it is likely multifactorial, and additional studies are needed to further evaluate this phenomenon. |
format | Online Article Text |
id | pubmed-8930020 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-89300202022-03-24 A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia Staiano, Peter P Patel, Shaorinkumar Green, Kevin R Louis, Mariam Hatoum, Hadi Cureus Infectious Disease Introduction Pneumomediastinum and pneumothorax are uncommon complications in COVID-19 patients. The exact prevalence, etiology, and outcomes are not well known. We report a case series of patients in our institution with COVID-19 related pneumomediastinum and pneumothorax and address these questions. Methods We conducted a single-center retrospective chart review of patients admitted at our institution with a positive polymerase chain reaction (PCR) confirming the diagnosis of COVID-19. A cohort of 500 potential study candidates was identified, of whom eight were investigated. Demographic data, hospital course, patient co-morbidities, and outcome data were collected. Results Eight patients were included in our study who were identified as having an event (i.e., pneumomediastinum and/or pneumothorax) during the specified timeframe. Overall, 62% of patients were on high-flow nasal cannula with an average FiO(2) of >70%. The average oxygen saturation//fraction of inspired oxygen (SpO(2)/FiO(2)) ratio leading up to an event was 113.7286 (range: 101.11-130.66), and all of the patients not on mechanical ventilation met the criteria for acute respiratory distress syndrome (ARDS) based on the Kigali definition with SpO(2)/FiO(2) < 315. The three patients who developed an event while requiring mechanical ventilation both had PaO(2)/FiO(2) < 100, consistent with severe ARDS at the time of an event. The mean time in days, counted from the day of hospital admission until an event, was 10 days (range: 3-23 days). None of the cases had documented pulmonary parenchymal disease prior to developing COVID-19. To the best of our knowledge, these events were not iatrogenic in nature. Conclusion Secondary spontaneous pneumomediastinum and pneumothorax are rare albeit well-documented phenomena in hospitalized patients with COVID-19 infection. Interestingly, the majority of patients in our study were on high-flow nasal cannula at the time of an event. The majority of previously published data on this topic are on those who required positive pressure ventilation; however, there have been more recent papers that also describe these events in non-mechanically ventilated patients. The exact pathophysiology remains unknown, but it is likely multifactorial, and additional studies are needed to further evaluate this phenomenon. Cureus 2022-02-15 /pmc/articles/PMC8930020/ /pubmed/35340519 http://dx.doi.org/10.7759/cureus.22247 Text en Copyright © 2022, Staiano et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Infectious Disease Staiano, Peter P Patel, Shaorinkumar Green, Kevin R Louis, Mariam Hatoum, Hadi A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia |
title | A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia |
title_full | A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia |
title_fullStr | A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia |
title_full_unstemmed | A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia |
title_short | A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia |
title_sort | case series of secondary spontaneous pneumomediastinum and pneumothorax in severe covid-19 pneumonia |
topic | Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930020/ https://www.ncbi.nlm.nih.gov/pubmed/35340519 http://dx.doi.org/10.7759/cureus.22247 |
work_keys_str_mv | AT staianopeterp acaseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia AT patelshaorinkumar acaseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia AT greenkevinr acaseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia AT louismariam acaseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia AT hatoumhadi acaseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia AT staianopeterp caseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia AT patelshaorinkumar caseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia AT greenkevinr caseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia AT louismariam caseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia AT hatoumhadi caseseriesofsecondaryspontaneouspneumomediastinumandpneumothoraxinseverecovid19pneumonia |